Brainstem injection of lidocaine releases the descending pain-inhibitory mechanisms in a rat model of mononeuropathy

Nayef E. Saadé, Hassen Al Amin, Jad Barchini, Sima Tchachaghian, Farah Shamaa, Suhayl J. Jabbur, Samir F. Atweh

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Lidocaine injections in the rostral ventromedial medulla (RVM) have been shown to produce significant reduction of neuropathic manifestations in rats. This effect has been attributed to selective block of a pain descending facilitatory system, responsible for chronic pain. However, recent observations from our laboratory did not provide confirmation to this hypothesis. We aimed, therefore, to investigate the spinal synaptic mechanisms activated by lidocaine injections in the RVM. Rats were subjected, under deep anesthesia, to the induction of mononeuropathy on one hindpaw, and to the stereotaxic implantation of chronic cannulae in the RVM for the injection of lidocaine or GABA antagonists. Implanted intrathecal catheter in the lumbosacral space was used for the injection of specific antagonists to GABA, 5HT, glycine, noreadrenaline and dopamine, prior to lidocaine. Tactile and cold hyperreactivity and heat hyperalgesia were assessed using von Frey hair filaments, acetone drop test and heat-induced paw withdrawal, respectively. Lidocaine injections produced significant inhibition of all neuropathic manifestations. Intrathecal injection of antagonists to GABA (bicucullin, picrotoxin and saclofen), serotonin 5HT 1-2 (ketanserin and methysergide) and α- (phentoalmine, yohimbine) and β- (propranolol) adrenergic receptors, suppressed the lidocaine inhibitory effects; while partial or no attenuation were observed following pretreatment with glycine and dopamine D 2/3 antagonists. Comparable effects were observed with RVM injection of GABA antagonists. Lidocaine injection in the RVM results in a release of the descending pain-inhibitory systems from a tonic gabaergic inhibition. This descending system involves the activation of gabaergic, serotonergic and adrenergic mechanisms at the level of the spinal dorsal horn.

Original languageEnglish
Pages (from-to)180-190
Number of pages11
JournalExperimental Neurology
Volume237
Issue number1
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Mononeuropathies
Lidocaine
Brain Stem
GABA Antagonists
Pain
Injections
Glycine
Dopamine
Hot Temperature
Methysergide
Spinal Injections
Ketanserin
Picrotoxin
Yohimbine
Hyperalgesia
Touch
Acetone
Propranolol
Chronic Pain
Adrenergic Agents

Keywords

  • 5HT
  • Catecholamines
  • Descending inhibition
  • GABA
  • Neuropathic pain
  • RVM

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Brainstem injection of lidocaine releases the descending pain-inhibitory mechanisms in a rat model of mononeuropathy. / Saadé, Nayef E.; Al Amin, Hassen; Barchini, Jad; Tchachaghian, Sima; Shamaa, Farah; Jabbur, Suhayl J.; Atweh, Samir F.

In: Experimental Neurology, Vol. 237, No. 1, 09.2012, p. 180-190.

Research output: Contribution to journalArticle

Saadé, Nayef E. ; Al Amin, Hassen ; Barchini, Jad ; Tchachaghian, Sima ; Shamaa, Farah ; Jabbur, Suhayl J. ; Atweh, Samir F. / Brainstem injection of lidocaine releases the descending pain-inhibitory mechanisms in a rat model of mononeuropathy. In: Experimental Neurology. 2012 ; Vol. 237, No. 1. pp. 180-190.
@article{1f4b3b5123fd4b11927383e9b379901f,
title = "Brainstem injection of lidocaine releases the descending pain-inhibitory mechanisms in a rat model of mononeuropathy",
abstract = "Lidocaine injections in the rostral ventromedial medulla (RVM) have been shown to produce significant reduction of neuropathic manifestations in rats. This effect has been attributed to selective block of a pain descending facilitatory system, responsible for chronic pain. However, recent observations from our laboratory did not provide confirmation to this hypothesis. We aimed, therefore, to investigate the spinal synaptic mechanisms activated by lidocaine injections in the RVM. Rats were subjected, under deep anesthesia, to the induction of mononeuropathy on one hindpaw, and to the stereotaxic implantation of chronic cannulae in the RVM for the injection of lidocaine or GABA antagonists. Implanted intrathecal catheter in the lumbosacral space was used for the injection of specific antagonists to GABA, 5HT, glycine, noreadrenaline and dopamine, prior to lidocaine. Tactile and cold hyperreactivity and heat hyperalgesia were assessed using von Frey hair filaments, acetone drop test and heat-induced paw withdrawal, respectively. Lidocaine injections produced significant inhibition of all neuropathic manifestations. Intrathecal injection of antagonists to GABA (bicucullin, picrotoxin and saclofen), serotonin 5HT 1-2 (ketanserin and methysergide) and α- (phentoalmine, yohimbine) and β- (propranolol) adrenergic receptors, suppressed the lidocaine inhibitory effects; while partial or no attenuation were observed following pretreatment with glycine and dopamine D 2/3 antagonists. Comparable effects were observed with RVM injection of GABA antagonists. Lidocaine injection in the RVM results in a release of the descending pain-inhibitory systems from a tonic gabaergic inhibition. This descending system involves the activation of gabaergic, serotonergic and adrenergic mechanisms at the level of the spinal dorsal horn.",
keywords = "5HT, Catecholamines, Descending inhibition, GABA, Neuropathic pain, RVM",
author = "Saad{\'e}, {Nayef E.} and {Al Amin}, Hassen and Jad Barchini and Sima Tchachaghian and Farah Shamaa and Jabbur, {Suhayl J.} and Atweh, {Samir F.}",
year = "2012",
month = "9",
doi = "10.1016/j.expneurol.2012.06.021",
language = "English",
volume = "237",
pages = "180--190",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Brainstem injection of lidocaine releases the descending pain-inhibitory mechanisms in a rat model of mononeuropathy

AU - Saadé, Nayef E.

AU - Al Amin, Hassen

AU - Barchini, Jad

AU - Tchachaghian, Sima

AU - Shamaa, Farah

AU - Jabbur, Suhayl J.

AU - Atweh, Samir F.

PY - 2012/9

Y1 - 2012/9

N2 - Lidocaine injections in the rostral ventromedial medulla (RVM) have been shown to produce significant reduction of neuropathic manifestations in rats. This effect has been attributed to selective block of a pain descending facilitatory system, responsible for chronic pain. However, recent observations from our laboratory did not provide confirmation to this hypothesis. We aimed, therefore, to investigate the spinal synaptic mechanisms activated by lidocaine injections in the RVM. Rats were subjected, under deep anesthesia, to the induction of mononeuropathy on one hindpaw, and to the stereotaxic implantation of chronic cannulae in the RVM for the injection of lidocaine or GABA antagonists. Implanted intrathecal catheter in the lumbosacral space was used for the injection of specific antagonists to GABA, 5HT, glycine, noreadrenaline and dopamine, prior to lidocaine. Tactile and cold hyperreactivity and heat hyperalgesia were assessed using von Frey hair filaments, acetone drop test and heat-induced paw withdrawal, respectively. Lidocaine injections produced significant inhibition of all neuropathic manifestations. Intrathecal injection of antagonists to GABA (bicucullin, picrotoxin and saclofen), serotonin 5HT 1-2 (ketanserin and methysergide) and α- (phentoalmine, yohimbine) and β- (propranolol) adrenergic receptors, suppressed the lidocaine inhibitory effects; while partial or no attenuation were observed following pretreatment with glycine and dopamine D 2/3 antagonists. Comparable effects were observed with RVM injection of GABA antagonists. Lidocaine injection in the RVM results in a release of the descending pain-inhibitory systems from a tonic gabaergic inhibition. This descending system involves the activation of gabaergic, serotonergic and adrenergic mechanisms at the level of the spinal dorsal horn.

AB - Lidocaine injections in the rostral ventromedial medulla (RVM) have been shown to produce significant reduction of neuropathic manifestations in rats. This effect has been attributed to selective block of a pain descending facilitatory system, responsible for chronic pain. However, recent observations from our laboratory did not provide confirmation to this hypothesis. We aimed, therefore, to investigate the spinal synaptic mechanisms activated by lidocaine injections in the RVM. Rats were subjected, under deep anesthesia, to the induction of mononeuropathy on one hindpaw, and to the stereotaxic implantation of chronic cannulae in the RVM for the injection of lidocaine or GABA antagonists. Implanted intrathecal catheter in the lumbosacral space was used for the injection of specific antagonists to GABA, 5HT, glycine, noreadrenaline and dopamine, prior to lidocaine. Tactile and cold hyperreactivity and heat hyperalgesia were assessed using von Frey hair filaments, acetone drop test and heat-induced paw withdrawal, respectively. Lidocaine injections produced significant inhibition of all neuropathic manifestations. Intrathecal injection of antagonists to GABA (bicucullin, picrotoxin and saclofen), serotonin 5HT 1-2 (ketanserin and methysergide) and α- (phentoalmine, yohimbine) and β- (propranolol) adrenergic receptors, suppressed the lidocaine inhibitory effects; while partial or no attenuation were observed following pretreatment with glycine and dopamine D 2/3 antagonists. Comparable effects were observed with RVM injection of GABA antagonists. Lidocaine injection in the RVM results in a release of the descending pain-inhibitory systems from a tonic gabaergic inhibition. This descending system involves the activation of gabaergic, serotonergic and adrenergic mechanisms at the level of the spinal dorsal horn.

KW - 5HT

KW - Catecholamines

KW - Descending inhibition

KW - GABA

KW - Neuropathic pain

KW - RVM

UR - http://www.scopus.com/inward/record.url?scp=84863837811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863837811&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2012.06.021

DO - 10.1016/j.expneurol.2012.06.021

M3 - Article

VL - 237

SP - 180

EP - 190

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -